ThZeal - The Zeal

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Mansano Roy

(Last)

(First)

(Middle)

5343 OSTROM AVE.

(Street)

ENCINO

91316

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
OKMIN RESOURCES, INC. [ OKMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								3,000,000	D
Common Stock								1,250,000	I	By Roy Mansano MD APMC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
10% Convertible Loan	$0.03	04/08/2022		J⁽¹⁾		$1,925⁽¹⁾		04/08/2022	05/08/2025	Common Stock	64,167⁽²⁾	$0.00	$240,625	I	By Roy Mansano MD AMPC
Warrants	⁽³⁾	04/08/2022		J⁽³⁾		21,389		⁽³⁾	⁽³⁾	Common Stock	21,389	$0.00	2,673,611	I	By Roy Mansano MD AMPC
10% Convertible Loan	$0.03	04/08/2022		J⁽⁴⁾			$3,100⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	103,334⁽⁵⁾	$0.00	$237,525	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	04/08/2022		J⁽⁶⁾			34,445	⁽⁶⁾	⁽⁶⁾	Common Stock	34,445	$0.00	2,639,166	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	05/08/2022		J⁽¹⁾		$1,899.17⁽¹⁾		05/08/2022	05/08/2025	Common Stock	63,306⁽⁷⁾	$0.00	$239,424.17	I	By Roy Mansano MD APMC
Warrants	⁽³⁾	05/08/2022		J⁽³⁾		21,102		⁽³⁾	⁽³⁾	Common Stock	21,102	$0.00	2,660,268	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	05/08/2022		J⁽⁴⁾			$4,600⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	153,333⁽⁸⁾	$0.00	$234,824.17	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	05/08/2022		J⁽⁶⁾			51,111	⁽⁶⁾	⁽⁶⁾	Common Stock	51,111	$0.00	2,609,157	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	06/08/2022		J⁽¹⁾		$1,860.83⁽¹⁾		06/08/2022	05/08/2025	Common Stock	62,027⁽⁹⁾	$0.00	$236,685	I	By Roy Mansano MD APMC
Warrants	⁽³⁾	06/08/2022		J⁽³⁾		20,676		⁽³⁾	⁽³⁾	Common Stock	20,676	$0.00	2,629,833	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	06/08/2022		J⁽⁴⁾			$4,040⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	134,667⁽¹⁰⁾	$0.00	$232,645	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	06/08/2022		J⁽⁶⁾			44,889	⁽⁶⁾	⁽⁶⁾	Common Stock	44,889	$0.00	2,584,944	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	07/08/2022		J⁽¹⁾		$1,827.17⁽¹⁾		07/08/2022	05/08/2025	Common Stock	60,906⁽¹¹⁾	$0.00	$234,472.17	I	By Roy Mansano MD APMC
Warrants	⁽³⁾	07/08/2022		J⁽³⁾		20,302		⁽³⁾	⁽³⁾	Common Stock	20,302	$0.00	2,605,246	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	07/08/2022		J⁽⁴⁾			$7,125⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	237,500⁽¹²⁾	$0.00	$227,347.17	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	07/08/2022		J⁽⁶⁾			79,167	⁽⁶⁾	⁽⁶⁾	Common Stock	79,167	$0.00	2,526,079	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	08/08/2022		J⁽¹⁾		$1,767.79⁽¹⁾		08/08/2022	05/08/2025	Common Stock	58,927⁽¹³⁾	$0.00	$229,114.96	I	By Roy Mansano MD APMC
Warrants	⁽³⁾	08/08/2022		J⁽³⁾		19,643		⁽³⁾	⁽³⁾	Common Stock	19,643	$0.00	2,545,722	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	08/08/2022		J⁽⁴⁾			$3,500⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	116,667⁽¹⁴⁾	$0.00	$225,614.96	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	08/08/2022		J⁽⁶⁾			38,889	⁽⁶⁾	⁽⁶⁾	Common Stock	38,889	$0.00	2,506,833	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	09/08/2022		J⁽¹⁾		$1,738.63⁽¹⁾		09/08/2021	05/08/2025	Common Stock	57,954⁽¹⁵⁾	$0.00	$227,353.59	I	By Roy Mansano MD APMC
Warrants	⁽³⁾	09/08/2022		J⁽³⁾		19,318		⁽³⁾	⁽³⁾	Common Stock	19,318	$0.00	2,526,151	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	09/08/2022		J⁽⁴⁾			$2,500⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	83,333⁽¹⁶⁾	$0.00	$224,853.59	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	09/08/2022		J⁽⁶⁾			27,778	⁽⁶⁾	⁽⁶⁾	Common Stock	27,778	$0.00	2,498,373	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	10/08/2022		J⁽¹⁾		$1,717.79⁽¹⁾		10/08/2022	05/08/2025	Common Stock	57,260⁽¹⁷⁾	$0.00	$226,571.38	I	By Roy Mansano MD APMC
Warrants	⁽³⁾	10/08/2022		J⁽³⁾		19,087		⁽³⁾	⁽³⁾	Common Stock	19,087	$0.00	2,517,460	I	By Roy Mansano MD APMC
10% Convertible Loan	$0.03	10/08/2022		J⁽⁴⁾			$3,500⁽⁴⁾	11/17/2021	05/08/2025	Common Stock	116,667⁽¹⁸⁾	$0.00	$223,071.38	I	By Roy Mansano MD APMC
Warrants	⁽⁶⁾	10/08/2022		J⁽⁶⁾			38,889	⁽⁶⁾	⁽⁶⁾	Common Stock	38,889	$0.00	2,478,571	I	By Roy Mansano MD APMC

Explanation of Responses:

1. Represents interest accrued on the 10% Convertible Loan (the "Loan") on this date. The outstanding principal and accrued interest on the Loan (the "Loan Amount") is convertible at any time into shares of Common Stock at a conversion price of $0.03 per share. For every three shares of Common Stock received upon conversion of the Loan Amount, the holder will also receive one Warrant to buy an additional share of Common Stock at an exercise price of $0.03 per share. The Warrants underlying the Loan Amount are also reported on this form.

2. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 8,020,834.

3. These Warrants are not currently outstanding but may be issued upon conversion of the interest that was accrued on the Loan on this date. The Warrants will be exercisable immediately if and when issued and will have an exercise price of $0.03 per share and a three-year term.

4. Represents a Loan payment on this date, which reduced the Loan Amount by the amount of the payment.

5. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,917,500.

6. These Warrants were subject to issuance upon conversion of the Loan Amount that was paid on this date. The Warrants would have been exercisable immediately if and when issued and would have had an exercise price of $0.03 per share and a three-year term.

7. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,980,806.

8. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,827,473.

9. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,889,500.

10. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,754,833.

11. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,815,739.

12. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,578,239.

13. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,637,166.

14. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,520,499.

15. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,578,453.

16. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,495,120.

17. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,552,380.

18. The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,435,713.

Remarks:

	/s/ Roy Mansano	01/06/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.